GBCS · Selectis Health, Inc.
$5.42
+0.12 (+2.26%)
At close · Aug 27
Going-concern doubt
— cleared Aug 24, 2026
The latest filing states the doubt was alleviated.
“As a result of the Company’s historical losses and projected cash needs, substantial doubt exists about the Company’s ability to continue as a going concern. The focus on opportunities within the Company’s current portfolio and future properties to acquire and operate, the settlement, refinance, and continued service of debt obligations, the potential funds generated from stock sales and other initiatives contributing to additional working capital should alleviate any substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Aug 24, 2026
Market Cap
$16.62M
Shares
3.07M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2020-12-31 | $101,563 | 10-K, filed 2022-08-26 |
| 2018-12-31 | $132,795 | 10-K, filed 2020-07-10 |